Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
Crossref DOI link: https://doi.org/10.1007/s00508-016-1016-7
Published Online: 2016-06-09
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weiss, Thomas W.
Aichinger, Josef
Huber, Kurt
Speidl, Walter S.
Watzinger, Norbert
Zweiker, Robert
Alber, Hannes F.
Funding for this research was provided by:
AstraZeneca
License valid from 2016-06-01